M. Hammond

发表

Tissue Micro-Array: A Cost and Time-Effective Method for Correlative Studies by Regional and National Cancer Study Groups

Martha Milanes-Yearsley, M. Hammond, T. Pajak, 2002, Modern Pathology.

Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update.

C. Perou, M. Dowsett, S. Lakhani, 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Estrogen and Progesterone Receptor Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Guideline Update.

David L Rimm, Charles M Perou, Lisa M McShane, 2020, Archives of pathology & laboratory medicine.

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer.

Anthony Rhodes, Paul Valenstein, Keith Miller, 2010, Archives of pathology & laboratory medicine.

The challenge of variation in medical practice.

M E Hammond, M. Hammond, B. James, 2009, Archives of pathology & laboratory medicine.

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer (unabridged version).

Anthony Rhodes, Paul Valenstein, Keith Miller, 2010, Archives of pathology & laboratory medicine.

Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update.

John M S Bartlett, Patrick Fitzgibbons, Mitch Dowsett, 2014, Archives of pathology & laboratory medicine.

The critical role of the pathologist in determining eligibility for active surveillance as a management option in patients with prostate cancer: consensus statement with recommendations supported by the College of American Pathologists, International Society of Urological Pathology, Association of D

Lawrence D. True, Beatrice S. Knudsen, Mark A. Rubin, 2014, Archives of pathology & laboratory medicine.

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer.

Anthony Rhodes, Lisa M McShane, Soonmyung Paik, 2006, Archives of pathology & laboratory medicine.

NCCN Task Force Report: Estrogen Receptor and Progesterone Receptor Testing in Breast Cancer by Immunohistochemistry.

Donald A Berry, D. Berry, A. Gown, 2009, Journal of the National Comprehensive Cancer Network : JNCCN.

Variable specimen handling affects hormone receptor test results in women with breast cancer: a large multihospital retrospective study.

M. Hammond, W. Sause, F. Nkoy, 2010, Archives of pathology & laboratory medicine.

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer.

Anthony Rhodes, Lisa M McShane, Soonmyung Paik, 2007, Archives of pathology & laboratory medicine.

HER2 testing in breast cancer: NCCN Task Force report and recommendations.

B. Ljung, E. Winer, E. Perez, 2006, Journal of the National Comprehensive Cancer Network : JNCCN.

Recommendations for validating estrogen and progesterone receptor immunohistochemistry assays.

M. Hammond, D. Allred, D. Murphy, 2010, Archives of pathology & laboratory medicine.

Predictive Biomarkers in Breast Cancer: ER, PR and Her-2/neu

M. Hammond, D. Hicks, J. Prichard, 2015 .

Prognostic factors in colorectal cancer

Clive R. Taylor, C. Compton, D. Sargent, 2009 .

ASCO-CAP Guidelines for Breast Predictive Factor Testing: An Update

M. Hammond, 2011, Applied immunohistochemistry & molecular morphology : AIMM.

American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer.

Anthony Rhodes, Paul Valenstein, Keith Miller, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

THE BOTTOM LINE Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer : American Society of Clinical Oncology / College of American Pathologists Clinical Practice Guideline Focused Update Guideline Questions

I. Ellis, M. Dowsett, M. Hammond, 2018 .

Re: predictability of adjuvant trastuzumab benefit in N9831 patients using the ASCO/CAP HER2-positivity criteria.

M. Hammond, A. Wolff, D. Hayes, 2012, Journal of the National Cancer Institute.

Clinical Notice for American Society of Clinical Oncology-College of American Pathologists guideline recommendations on ER/PgR and HER2 testing in breast cancer.

M. Hammond, A. Wolff, D. Hayes, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Fixation time does not affect expression of HER2/neu.

A. Gown, M. Hammond, M. Beasley, 2011, American journal of clinical pathology.

College of American Pathologists Conference XXVI on clinical relevance of prognostic markers in solid tumors. Summary. Members of the Cancer Committee.

D. Grignon, M. Hammond, D. Henson, 1995, Archives of pathology & laboratory medicine.

Conference summary, Strategic Science symposium. Her-2/neu testing of breast cancer patients in clinical practice.

M. Hammond, R. Zarbo, 2003, Archives of pathology & laboratory medicine.

Large cell neuroendocrine tumors of the lung clinical significance and histopathologic definition

M. Hammond, W. Sause, William T. Sause, 1985, Cancer.

Analysis of the effect of p16 and tobacco pack-years (p-y) on overall (OS) and progression-free survival (PFS) for patients with oropharynx cancer (OPC) in Radiation Therapy Oncology Group (RTOG) protocol 9003.

K. Ang, M. Hammond, C. Chung, 2010 .

Lack of prognostic significance of p53 and K-ras mutations in primary resected non-small-cell lung cancer on E4592: a Laboratory Ancillary Study on an Eastern Cooperative Oncology Group Prospective Randomized Trial of Postoperative Adjuvant Therapy.

J. Jett, M. Hammond, R. Livingston, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Quantitative Image Analysis of Human Epidermal Growth Factor Receptor 2 Immunohistochemistry for Breast Cancer: Guideline From the College of American Pathologists.

L. Pantanowitz, A. Madabhushi, Carol Colasacco, 2019, Archives of pathology & laboratory medicine.

Antisense-MDM2 sensitizes LNCaP prostate cancer cells to androgen deprivation, radiation, and the combination in vivo.

R. Stoyanova, M. Hammond, S. Agrawal, 2007, International journal of radiation oncology, biology, physics.

RENAL DEPOSITION OF CYTOMEGALOVIRUS ANTIGEN IN IMMUNOGLOBULIN-A NEPHROPATHY

M. Hammond, M. Gregory, E. Brewer, 1988, The Lancet.

Margins for breast-conserving surgery with whole-breast irradiation in stage I and II invasive breast cancer: American Society of Clinical Oncology endorsement of the Society of Surgical Oncology/American Society for Radiation Oncology consensus guideline.

J. Griggs, M. Somerfield, L. Newman, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Protocol for the examination of specimens from patients with thymic epithelial tumors located in any area of the mediastinum.

S. Suster, A. Marchevsky, M. Hammond, 2003, Archives of pathology & laboratory medicine.

Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Focused Update.

Ian Krop, Fabrice Andre, Vered Stearns, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Tricuspid valve replacement after cardiac transplantation.

D. Renlund, A. Kfoury, M. Hammond, 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

MDM2 as a predictor of prostate carcinoma outcome

D. Grignon, M. Hammond, H. Sandler, 2005, Cancer.

Malignant Lymphomas Exhibiting Positive Immunohistochemical Staining for Neuron Specdic Enolase

M. Hammond, M. Rabkin, C. Kjeldsberg, 1988 .

Correlation Between Cellular Rejection of Cardiac Allografts and Quantitative Changes Among T‐Cell Subsets Identified by Vβ, Epitope Expression

J. Carlquist, Jeffrey L. Anderson, M. Hammond, 1994, Circulation.

A clinical correlation study of severity of antibody-mediated rejection and cardiovascular mortality in heart transplantation.

D. Renlund, A. Kfoury, P. Fisher, 2009, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Cardiac retransplantation: a viable option? The Registry of the International Society for Heart and Lung Transplantation.

D. Renlund, M. Hammond, W. Richenbacher, 1992, The Annals of thoracic surgery.

Cardiac allograft vascular (microvascular) rejection

D. Renlund, M. Hammond, 2002 .

A PROSPECTIVE COMPARISON OF MURINE MONOCLONAL CD‐3 (OKT3) ANTIBODY‐BASED AND EQUINE ANTITHYMOCYTE GLOBULIN‐BASED REJECTION PROPHYLAXIS IN CARDIAC TRANSPLANTATION

D. Renlund, M. Hammond, M. Bristow, 1989, Transplantation.

An Overview of Clinical Development of Agents for Metastatic or Advanced Breast Cancer Without ERBB2 Amplification (HER2-Low).

A. Bardia, M. Hammond, G. Viale, 2022, JAMA oncology.

Early failure of a tricuspid valve replacement with a mitral valve homograft in a heart transplant recipient.

D. Renlund, M. Hammond, R. Shaddy, 2004, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Chronic encephalitis, epilepsy, and cerebrovascular immune complex deposits

M. Hammond, T. Pysher, M. Walker, 1990, Annals of neurology.

HER2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update Summary.

M. Dowsett, M. Hammond, L. McShane, 2018, Journal of oncology practice.

Commentary: improving breast cancer testing for patients-the secret sauce is collaboration.

M. Hammond, 2010, Journal of oncology practice.

Hypocomplementemic urticarial vasculitis syndrome responsive to dapsone.

M. Hammond, J. Zone, G. Groggel, 1986, Journal of the American Academy of Dermatology.

Accelerated rejection of murine cardiac allografts by murine cytomegalovirus-infected recipients. Lack of haplotype specificity.

J. Carlquist, M. Hammond, J. Anderson, 1993, The Journal of clinical investigation.

Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update.

John M S Bartlett, Patrick Fitzgibbons, Mitch Dowsett, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Reply to R. Bhargava et al and K. Lambein et al.

M. Dowsett, M. Hammond, L. McShane, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

American Society of Clinical Oncology/College of American Pathologists Human Epidermal Growth Factor Receptor 2 Testing Clinical Practice Guideline Upcoming Modifications: Proof That Clinical Practice Guidelines Are Living Documents.

M. Hammond, D. Hicks, M. Elizabeth H. Hammond, 2015, Archives of pathology & laboratory medicine.

Reply to E.A. Rakha et al.

E. Perez, M. Dowsett, M. Hammond, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Correlation of prostate‐specific acid phosphatase and prostate‐specific antigen immunocytochemistry with survival in prostate carcinoma

P. Rubin, M. Hammond, W. Sause, 1989, Cancer.

Evidence for an autocrine/paracrine function of chorionic gonadotropin in Xanthomonas maltophilia.

M. Hammond, D. Carrell, W. Odell, 1993, Endocrinology.

Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999.

M E Hammond, C C Compton, D J Sargent, 2000, Archives of pathology & laboratory medicine.

Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update.

John M S Bartlett, Patrick Fitzgibbons, Lisa M McShane, 2018, Archives of pathology & laboratory medicine.

Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update.

John M S Bartlett, Patrick Fitzgibbons, Lisa M McShane, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Genetic heterogeneity in HER2 testing in breast cancer: panel summary and guidelines.

Raymond R Tubbs, Patrick L Fitzgibbons, K. Bloom, 2009, Archives of pathology & laboratory medicine.

A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation.

M. Hammond, C. Marboe, N. Cary, 1990, The Journal of heart transplantation.

Randomized trial of hyperfractionation versus conventional fractionation in T2 squamous cell carcinoma of the vocal cord (RTOG 9512).

Christopher U. Jones, K. Ang, M. Hammond, 2014, International journal of radiation oncology, biology, physics.

Ki-67 staining is a strong predictor of distant metastasis and mortality for men with prostate cancer treated with radiotherapy plus androgen deprivation: Radiation Therapy Oncology Group Trial 92-02.

M. Hammond, H. Sandler, M. Desilvio, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Vascular endothelial growth factor (VEGF) expression in locally advanced prostate cancer: secondary analysis of radiation therapy oncology group (RTOG) 8610

M. Hammond, A. Dicker, A. Pollack, 2003, Radiation oncology.

Protocols for the examination of tumors of diverse sites: introduction. Cancer committee of the College of American Pathologists.

M E Hammond, C C Compton, M. Hammond, 2009, Archives of pathology & laboratory medicine.

COX-2 expression predicts prostate-cancer outcome: analysis of data from the RTOG 92-02 trial.

D. Grignon, M. Hammond, H. Sandler, 2007, The Lancet. Oncology.

NCCN Task Force report: Evaluating the clinical utility of tumor markers in oncology.

P. Febbo, K. Aldape, M. Ladanyi, 2011, Journal of the National Comprehensive Cancer Network : JNCCN.

Glioma-associated oncogene family zinc finger 1 expression and metastasis in patients with head and neck squamous cell carcinoma treated with radiation therapy (RTOG 9003).

K. Ang, M. Hammond, J. Cooper, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The role of KRAS mutation testing in the management of patients with metastatic colorectal cancer.

K. Bloom, M. Hammond, S. Ogino, 2009, Archives of pathology & laboratory medicine.

Microvessel Density ≥60 Does Not Predict for Outcome After Radiation Treatment for Locally Advanced Head and Neck Squamous Cell Carcinoma: Results of a Correlative Study From the Radiation Therapy Oncology Group (RTOG) 90-03 Trial

Christopher U. Jones, K. Ang, M. Hammond, 2007, American journal of clinical oncology.

Bias in Medicine

A. Kfoury, M. Hammond, S. Drakos, 2021, JACC. Basic to translational science.

Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: ASCO Clinical Practice Guideline Update-Integration of Results From TAILORx.

Fabrice Andre, Vered Stearns, R. Bast, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prognostic factors in prostate cancer. College of American Pathologists Consensus Statement 1999.

Daniel S. Miller, D. Bostwick, D. Grignon, 2000, Archives of pathology & laboratory medicine.

Issues and barriers to development of clinically useful tumor markers: a development pathway proposal.

M. Hammond, S. Taube, Sheila E. Taube, 2002, Seminars in oncology.

College of American Pathologists Conference XXXV: solid tumor prognostic factors-which, how and so what? Summary document and recommendations for implementation. Cancer Committee and Conference Participants.

C. Compton, D. Bostwick, D. Grignon, 2000, Archives of pathology & laboratory medicine.

JNCCN HER 2 Testing in Breast Cancer : NCCN Task Force Report and Recommendations

B. Ljung, E. Winer, E. Perez, 2006 .

Ki-67 Staining Index Predicts Distant Metastasis and Survival in Locally Advanced Prostate Cancer Treated With Radiotherapy

D. Grignon, M. Hammond, H. Sandler, 2004, Clinical Cancer Research.

Statistical issues in tumor marker studies.

D. Sargent, M. Hammond, T. Pajak, 2000, Archives of pathology & laboratory medicine.

Updated protocol for the examination of specimens from patients with carcinomas of the prostate gland: a basis for checklists. Cancer Committee.

M E Hammond, D. Bostwick, D. Grignon, 2000, Archives of pathology & laboratory medicine.

Addressing the maintenance of certification challenge: the College of American Pathologists response.

M. Hammond, H. Homburger, C. Filling, 2009, Archives of pathology & laboratory medicine.

Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer-Clinical Notice

Anthony Rhodes, Paul Valenstein, Daniel F. Hayes, 2010 .

American society of clinical oncology/college of american pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer.

M. Dowsett, D. Visscher, M. Hammond, 2010, Journal of oncology practice.

Perirenal malignant schwannoma: a case report and review of the literature.

M. Hammond, H. E. Parfitt, A. Middleton, 1982, The Journal of urology.

MDM2 and Ki-67 predict for distant metastasis and mortality in men treated with radiotherapy and androgen deprivation for prostate cancer: RTOG 92-02.

Kyounghwa Bae, Alan Pollack, D. Grignon, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The Tissue Microarray—A Technical Guide for Histologists

M. Hammond, Thom Jensen, 2001 .

C. Compton, D. Bostwick, D. Grignon, 2000, Archives of pathology & laboratory medicine.

Bcl-2 and bax expression and prostate cancer outcome in men treated with radiotherapy in Radiation Therapy Oncology Group protocol 86-10.

T. McDonnell, M. Hammond, H. Sandler, 2006, International journal of radiation oncology, biology, physics.

The Importance of Protein Kinase A in Prostate Cancer: Relationship to Patient Outcome in Radiation Therapy Oncology Group Trial 92-02

M. Hammond, H. Sandler, K. Bae, 2009, Clinical Cancer Research.

The use of circulating donor specific antibody to predict biopsy diagnosis of antibody-mediated rejection and to provide prognostic value after heart transplantation in children.

A. Kfoury, M. Hammond, M. Revelo, 2016, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

In reply [3]

Antonio C. Wolff, M. Hammond, A. Wolff, 2007 .

Allograft rejection in patients supported with continuous-flow left ventricular assist devices.

Amit N. Patel, A. Kfoury, M. Hammond, 2011, The Annals of thoracic surgery.

Conference Summary, Strategic Science Symposium

M. Hammond, R. Zarbo, 2009 .

Brain tumor committee

W. Yung, M. Prados, G. Barger, 2001 .

Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: ASCO–College of American Pathologists Guideline Update

M. Dowsett, M. Somerfield, M. Hammond, 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

College of American Pathologists Conference XXXV: Solid Tumor Prognostic Factors—Which, How and So What?

C. Compton, D. Bostwick, D. Grignon, 2009 .

ISHLT pathology antibody mediated rejection score correlates with increased risk of cardiovascular mortality: A retrospective validation analysis.

A. Kfoury, M. Hammond, C. Selzman, 2016, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

The role of the indispensable surgical pathologist in treatment planning for breast cancer.

M. Hammond, D. Hicks, S. Kulkarni, 2008, Archives of Pathology & Laboratory Medicine.

Updated protocol for the examination of specimens from patients with carcinoma of the urinary bladder, ureter, and renal pelvis.

Mahul B Amin, Victor E Reuter, D. Grignon, 2003, Archives of pathology & laboratory medicine.

Quality and the college of american pathologists.

M. Hammond, S. Robboy, T. Allen, 2011, Archives of pathology & laboratory medicine.

Pathology Standards in Cancer Informatics

M. Hammond, K. Spackman, 2002 .

Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology-College of American Pathologists Guideline Update.

M. Dowsett, M. Somerfield, M. Hammond, 2023, Archives of pathology & laboratory medicine.

Variable specimen handling affects hormone receptor test results in women with breast cancer: a large multihospital retrospective study.

M. Hammond, W. Sause, F. Nkoy, 2010, Archives of pathology & laboratory medicine.

M. Rubin, A. Chinnaiyan, B. Delahunt, 2014, Archives of pathology & laboratory medicine.

Association of high Gli1 expression with poor survival in head and neck cancer patients treated with radiation therapy (RTOG 9003).

K. Ang, M. Hammond, J. Cooper, 2010 .